September 15, 2017 / 10:52 AM / in 2 months

BRIEF-XBiotech - European Medicines Agency maintains its May 18, 2017 opinion

Sept 15 (Reuters) - XBiotech Inc

* XBiotech - on Sept 14, although there were advancements in certain areas of application European Medicines Agency has maintained its May 18, 2017 opinion

* XBiotech says EMA's opinion maintained following re-examination of its Marketing Authorization Application for its lead product candidate in EUROPE- SEC filing Source text for Eikon: [bit.ly/2h6RUnU] Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below